Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators
Ivan V. Litvinov, Michael T. Tetzlaff, P Thibault, et al.
OncoImmunology (2017) Vol. 6, Iss. 5, pp. e1306618-e1306618
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
Anita G. Seto, Xuan Beatty, Joshua M. Lynch, et al.
British Journal of Haematology (2018) Vol. 183, Iss. 3, pp. 428-444
Open Access | Times Cited: 248
Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors
Alyxzandria M. Gaydosik, Tracy Tabib, Larisa J. Geskin, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 14, pp. 4443-4454
Open Access | Times Cited: 116
Artificial Intelligence Applications in Dermatology: Where Do We Stand?
Arieh Gomolin, Elena Netchiporouk, Robert Gniadecki, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 112
Mycosis Fungoides and Sézary Syndrome
Cecilia Larocca, Thomas S. Kupper
Hematology/Oncology Clinics of North America (2018) Vol. 33, Iss. 1, pp. 103-120
Open Access | Times Cited: 109
Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression
Nicholas Borcherding, Andrew P. Voigt, Vincent Liu, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 10, pp. 2996-3005
Open Access | Times Cited: 104
Single-cell heterogeneity in Sézary syndrome
Terkild B. Buus, Andreas Willerslev-Olsen, Simon Fredholm, et al.
Blood Advances (2018) Vol. 2, Iss. 16, pp. 2115-2126
Open Access | Times Cited: 97
Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures
Alberto Herrera, Anthony Cheng, Eleni P. Mimitou, et al.
Blood (2021) Vol. 138, Iss. 16, pp. 1456-1464
Open Access | Times Cited: 60
<p>Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma</p>
Thomas Ollila, İlyas Şahin, Adam J. Olszewski
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 1085-1094
Open Access | Times Cited: 62
Skin colonization by circulating neoplastic clones in cutaneous T-cell lymphoma
Aishwarya Iyer, Dylan Hennessey, Sandra OʼKeefe, et al.
Blood (2019) Vol. 134, Iss. 18, pp. 1517-1527
Open Access | Times Cited: 62
Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma
Aishwarya Iyer, Dylan Hennessey, Sandra O’Keefe, et al.
Blood Advances (2020) Vol. 4, Iss. 11, pp. 2489-2500
Open Access | Times Cited: 54
Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma
Katharina Rindler, Constanze Jonak, Natalia Alkon, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 43
CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver
Jan P. Nicolay, Jana D. Albrecht, Silvia Alberti Violetti, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1660-1671
Open Access | Times Cited: 42
Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
Maria Gluud, Emil M. H. Pallesen, Terkild B. Buus, et al.
Blood (2022) Vol. 141, Iss. 2, pp. 180-193
Open Access | Times Cited: 31
Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study
Lise M. Lindahl, Søren Besenbacher, Anne Hald Rittig, et al.
Blood (2017) Vol. 131, Iss. 7, pp. 759-770
Open Access | Times Cited: 50
Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma
Abdelbasset Hamrouni, H Fogh, Zoulika Zak, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 10, pp. 3104-3114
Open Access | Times Cited: 43
Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
Nuria García‐Díaz, Miguel Á. Piris, Pablo L. Ortiz‐Romero, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1931-1931
Open Access | Times Cited: 37
Vitamin D in Cutaneous T-Cell Lymphoma
August-Witte Feentved Ødum, Carsten Geisler
Cells (2024) Vol. 13, Iss. 6, pp. 503-503
Open Access | Times Cited: 5
Distribution and Clustering of Cutaneous T-Cell Lymphoma (CTCL) Cases in Canada During 1992 to 2010
Feras M. Ghazawi, Elena Netchiporouk, Elham Rahme, et al.
Journal of Cutaneous Medicine and Surgery (2017) Vol. 22, Iss. 2, pp. 154-165
Closed Access | Times Cited: 47
MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma
Xiaoyan Shen, Bo Wang, Kejia Li, et al.
Journal of Investigative Dermatology (2018) Vol. 138, Iss. 9, pp. 2024-2032
Open Access | Times Cited: 46
Analysis of CTCL cell lines reveals important differences between mycosis fungoides/Sézary syndrome vs. HTLV-1+ leukemic cell lines
Elena Netchiporouk, Jennifer Gantchev, Matthew Tsang, et al.
Oncotarget (2017) Vol. 8, Iss. 56, pp. 95981-95998
Open Access | Times Cited: 45
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia
Barbara Maurer, Harini Nivarthi, Bettina Wingelhofer, et al.
Haematologica (2019) Vol. 105, Iss. 2, pp. 435-447
Open Access | Times Cited: 40
Single Cell Resolution Tracking of Cutaneous T-Cell Lymphoma Reveals Clonal Evolution in Disease Progression
Hannah K. Dorando, Jared Andrews, Nicholas Borcherding, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Recent advances in understanding and managing cutaneous T-cell lymphomas
Patrick M. Brunner, Constanze Jonak, Robert Knobler
F1000Research (2020) Vol. 9, pp. 331-331
Open Access | Times Cited: 31
An Update on Molecular Biology of Cutaneous T Cell Lymphoma
Ritika Walia, Cecilia C.S. Yeung
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 30
Staphylococcus aureus alpha-toxin inhibits CD8 + T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma
Edda Blümel, Shamaila Munir Ahmad, Claudia Nastasi, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top